Bank of New York Mellon’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $7.27M | Buy |
|
|||||
|
2025
Q2 | $1.22M | Buy |
|
|||||
|
2025
Q1 | $1.19M | Buy |
|
|||||
|
2024
Q4 | $835K | Sell |
|
|||||
|
2024
Q3 | $1.22M | Sell |
|
|||||
|
2024
Q2 | $1.6M | Buy |
|
|||||
|
2024
Q1 | $1.33M | Buy |
|
|||||
|
2023
Q4 | $1.23M | Buy |
|
|||||
|
2023
Q3 | $812K | Buy |
|
|||||
|
2023
Q2 | $745K | Sell |
|
|||||
|
2023
Q1 | $652K | Sell |
|
|||||
|
2022
Q4 | $561K | Buy |
|
|||||
|
2022
Q3 | $1.2M | Buy |
|
|||||
|
2022
Q2 | $719K | Buy |
|
|||||
|
2022
Q1 | $1.03M | Buy |
|
|||||
|
2021
Q4 | $870K | Sell |
|
|||||
|
2021
Q3 | $1.28M | Sell |
|
|||||
|
2021
Q2 | $2.05M | Sell |
|
|||||
|
2021
Q1 | $2.84M | Buy |
|
|||||
|
2020
Q4 | $861K | Buy |
|
|||||
|
2020
Q3 | $529K | Sell |
|
|||||
|
2020
Q2 | $511K | Buy |
|
|||||
|
2020
Q1 | $268K | Buy |
|
|||||
|
2019
Q4 | $623K | Sell |
|
|||||
|
2019
Q3 | $428K | Sell |
|
|||||
|
2019
Q2 | $865K | Buy |
|
|||||
|
2019
Q1 | $204K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $7K | Sell |
|
|||||
|
2016
Q2 | $10K | Sell |
|
|||||
|
2016
Q1 | $25K | Hold |
|
|||||
|
2015
Q4 | $141K | Buy |
|
|||||
|
2015
Q3 | $133K | Sell |
|
|||||
|
2015
Q2 | $331K | Buy |
|